SMTL ID : 4bbx.1 (1 other biounit)

Discovery of a potent, selective and orally active PDE10A inhibitor for the treatment of schizophrenia

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x LKF: 4-[3-[1-[(2S)-2-methoxypropyl]pyrazol-4-yl]-2-methyl-imidazo[1,2-a]pyrazin-8-yl]morpholine(Non-covalent)

LKF.1: 10 residues within 4Å: Chain A: Y.74, S.121, L.185, L.225, I.242, F.246, M.263, M.264, Q.276, F.279 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.279 Hydrogen bonds: A:Q.276 pi-Stacking: A:F.246, A:F.279

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 6 residues within 4Å: Chain A: H.75, H.79, H.113, D.114, D.224 Ligands: MG.3 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.79, A:H.113, A:D.114, A:D.224, H2O.1

1 x MG: MAGNESIUM ION(Non-covalent)

MG.3: 3 residues within 4Å: Chain A: D.114, H.145 Ligands: ZN.2 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.114, H2O.1, H2O.1, H2O.1, H2O.1

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bartolome-Nebreda, J.M. et al., Discovery of a Potent, Selective and Orally Active Pde10A Inhibitor for the Potential Treatment of Schizophrenia. J.Med.Chem. (2014)

Release Date

2013-10-16

Peptides

CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A

Related Entries With Identical Sequence